Sec. 20. A practitioner who is permitted to distribute, dispense, prescribe, conduct research with respect to, or administer ephedrine, pseudoephedrine, or a controlled substance in the course of the practitioner's professional practice or research in the United States must be certified under section 19(d)(4) of this chapter to receive information from the INSPECT program.
As added by P.L.51-2019, SEC.8.
Structure Indiana Code
Title 25. Professions and Occupations
Article 26. Pharmacists, Pharmacies, Drug Stores
Chapter 24. Central Repository for Controlled Substances Data
25-26-24-2.5. "Controlled Substance"
25-26-24-5. "Exception Report"
25-26-24-6. "Identification Number"
25-26-24-8. "Interoperability"
25-26-24-9. "Pain Management Clinic"
25-26-24-13. "Pseudoephedrine"
25-26-24-15. "Recipient Representative"
25-26-24-17. Program Components; Recommendations; Retail Pharmacy
25-26-24-18. Program Requirements; Execution of Contracts; Data; Funding
25-26-24-19.5. Release of Inspect Information to a Veterinarian
25-26-24-20. Certification Requirement
25-26-24-21. Review by Governing Board of Dissemination of Exception Reports; Investigation
25-26-24-22. Rules; Standards; Intervention and Treatment
25-26-24-24. Committee; Members; Recommendations; Meetings; Term